Silverlake Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.32M Sell
25,854
-375
-1% -$87.3K 1.32% 8
2025
Q4
$5.43M Buy
26,229
+1,087
+4% +$215K 1.21% 11
2025
Q3
$4.66M Sell
25,142
-473
-2% -$81K 1.13% 12
2025
Q2
$3.91M Buy
25,615
+997
+4% +$153K 1.14% 10
2025
Q1
$4.08M Buy
24,618
+926
+4% +$145K 1.54% 8
2024
Q4
$3.43M Sell
23,692
-441
-2% -$68.3K 1.31% 9
2024
Q3
$3.91M Sell
24,133
-78
-0.3% -$12.4K 1.48% 8
2024
Q2
$3.54M Sell
24,211
-238
-1% -$35.4K 1.45% 8
2024
Q1
$3.87M Buy
24,449
+302
+1% +$48.1K 1.97% 5
2023
Q4
$3.78M Sell
24,147
-1,854
-7% -$284K 2.09% 5
2023
Q3
$4.05M Sell
26,001
-260
-1% -$42.9K 2.27% 4
2023
Q2
$4.35M Buy
26,261
+146
+0.6% +$23.6K 2.42% 5
2023
Q1
$4.05M Sell
26,115
-888
-3% -$143K 2.45% 5
2022
Q4
$4.77M Buy
27,003
+70
+0.3% +$12.1K 2.97% 5
2022
Q3
$4.4M Buy
26,933
+100
+0.4% +$16.9K 2.98% 5
2022
Q2
$4.76M Buy
26,833
+16
+0.1% +$2.85K 3.11% 4
2022
Q1
$4.75M Buy
26,817
+153
+0.6% +$26K 2.71% 4
2021
Q4
$4.56M Buy
+26,664
New +$4.37M 2.45% 4

Other funds holding JNJ

Silverlake Wealth Management's JNJ Position: Q1 2026 in Review

Silverlake Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q1 2026, selling an estimated $87.3K and leaving 25,854 shares worth $6.32M. The position accounts for 1.32% of the portfolio, ranked #8.

Silverlake Wealth Management first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Silverlake Wealth Management held 25,854 shares of Johnson & Johnson worth $6.32M as of Q1 2026.
  • Silverlake Wealth Management sold 375 Johnson & Johnson shares in Q1 2026, an estimated $87.3K.
  • Johnson & Johnson made up 1.32% of Silverlake Wealth Management's portfolio in Q1 2026, its #8 holding.
  • Silverlake Wealth Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Silverlake Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.